ATE350044T1 - Thrombopoietinmimetika - Google Patents
ThrombopoietinmimetikaInfo
- Publication number
- ATE350044T1 ATE350044T1 AT00965329T AT00965329T ATE350044T1 AT E350044 T1 ATE350044 T1 AT E350044T1 AT 00965329 T AT00965329 T AT 00965329T AT 00965329 T AT00965329 T AT 00965329T AT E350044 T1 ATE350044 T1 AT E350044T1
- Authority
- AT
- Austria
- Prior art keywords
- mammal
- invented
- thrombopoietin mimetics
- mimetics
- thrombopoietin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/46—Oxygen atom in position 3 or 5 and nitrogen atom in position 4
- C07D231/48—Oxygen atom in position 3 or 5 and nitrogen atom in position 4 with hydrocarbon radicals attached to said nitrogen atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15595899P | 1999-09-24 | 1999-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE350044T1 true ATE350044T1 (de) | 2007-01-15 |
Family
ID=22557467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00965329T ATE350044T1 (de) | 1999-09-24 | 2000-09-22 | Thrombopoietinmimetika |
Country Status (8)
Country | Link |
---|---|
US (1) | US6552008B1 (de) |
EP (1) | EP1223944B1 (de) |
JP (1) | JP2003509462A (de) |
AT (1) | ATE350044T1 (de) |
AU (1) | AU771460B2 (de) |
DE (1) | DE60032783T2 (de) |
ES (1) | ES2279769T3 (de) |
WO (1) | WO2001021180A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
US6887890B2 (en) | 2000-05-30 | 2005-05-03 | Chugai Seiyaku Kabushiki Kaisha | Compounds exhibiting thrombopoietin-like activities |
AU2002239718A1 (en) * | 2000-12-19 | 2002-07-01 | Ligand Pharmaceuticals | Thrombopoietin mimetics |
TWI280128B (en) | 2002-05-22 | 2007-05-01 | Smithkline Beecham Corp | 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
JP4412173B2 (ja) | 2002-08-14 | 2010-02-10 | 日産化学工業株式会社 | トロンボポエチンレセプター活性化剤ならびにそれらの製造方法 |
AU2003275077B2 (en) * | 2002-09-18 | 2010-02-04 | Ortho-Mcneil Pharmaceutical, Inc. | Methods of increasing platelet and hematopoietic stem cell production |
TWI324593B (en) * | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
US20090143453A1 (en) * | 2003-04-29 | 2009-06-04 | Connie Erickson-Miller | Methods for treating degenerative diseases/injuries |
US20100004302A1 (en) * | 2003-04-29 | 2010-01-07 | Connie Erickson-Miller | Methods for Treating Degenerative Diseases/Injuries |
US20090298179A1 (en) * | 2003-04-29 | 2009-12-03 | Connie Erickson-Miller | Methods For Treating Degenerative Diseases/Injuries |
US20090048318A1 (en) * | 2003-04-29 | 2009-02-19 | Connie Erickson-Miller | Methods for treating degenerative diseases/injuries |
WO2004096154A2 (en) * | 2003-04-29 | 2004-11-11 | Smithkline Beecham Corporation | Methods for treating degenerative diseases/injuries |
KR101227666B1 (ko) * | 2003-05-12 | 2013-01-31 | 아피맥스, 인크. | 에리스로포이에틴 수용체에 결합하는 펩티드 |
CA2525464A1 (en) | 2003-05-12 | 2004-11-25 | Qun Yin | Novel poly(ethylene glycol) modified compounds and uses thereof |
WO2004101606A2 (en) * | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
EP2204193A3 (de) * | 2003-05-12 | 2010-08-18 | Affymax, Inc. | Spacer-Bestandteile für Poly(ethylenglykol)-modifizierte Verbindungen auf Peptidbasis |
HUE032370T2 (en) | 2003-08-28 | 2017-09-28 | Janssen Pharmaceuticals Inc | Peptides and compounds that bind to thrombopoietin receptors |
US7723295B2 (en) | 2003-08-28 | 2010-05-25 | Ortho-Mcneil Pharmaceutical, Inc. | Peptides and compounds that bind to a receptor |
TW200526638A (en) | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
WO2005118551A2 (en) | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
BRPI0516883A (pt) | 2004-10-25 | 2008-09-23 | Ligand Pharm Inc | compostos e métodos para modulação da atividade de trombopoietina |
CN101142234A (zh) * | 2004-11-11 | 2008-03-12 | 阿费麦克斯公司 | 结合红细胞生成素受体的新肽 |
WO2006062685A2 (en) * | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
US7125446B2 (en) * | 2004-11-19 | 2006-10-24 | Eastman Kodak Company | Yellow dyes for ink jet inks |
CA2588979C (en) | 2004-12-08 | 2013-01-22 | Nissan Chemical Industries, Ltd. | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
WO2006064957A1 (ja) | 2004-12-14 | 2006-06-22 | Nissan Chemical Industries, Ltd. | アミド化合物及びトロンボポエチンレセプター活性化剤 |
US7919461B2 (en) | 2005-06-03 | 2011-04-05 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US8324159B2 (en) * | 2005-06-03 | 2012-12-04 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
WO2007010954A1 (en) | 2005-07-15 | 2007-01-25 | Nissan Chemical Industries, Ltd. | Thiophene compounds and thrombopoietin receptor activators |
JP5104752B2 (ja) | 2005-07-20 | 2012-12-19 | 日産化学工業株式会社 | ピラゾール化合物及びトロンボポエチンレセプター活性化剤 |
EP1947101A4 (de) | 2005-11-07 | 2009-09-16 | Nissan Chemical Ind Ltd | Hydrazidverbindung und thrombopoietinrezeptoraktivator |
KR20080080305A (ko) * | 2005-11-23 | 2008-09-03 | 리간드 파마슈티칼스 인코포레이티드 | 트롬보포이에틴 활성 조절 화합물 및 이의 조절 방법 |
EP2025671A4 (de) | 2006-06-07 | 2011-04-06 | Nissan Chemical Ind Ltd | Stickstoffhaltige heterocyclische verbindung und thrombopoietinrezeptoraktivator |
US7737149B2 (en) * | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
JP2010520855A (ja) * | 2007-01-31 | 2010-06-17 | アフィーマックス・インコーポレイテッド | 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー |
ECSP077628A (es) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
CN102123989A (zh) * | 2008-06-19 | 2011-07-13 | 阿斯利康(瑞典)有限公司 | 吡唑化合物436 |
PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
US8680150B2 (en) | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
PT3127427T (pt) | 2009-05-29 | 2020-04-17 | Novartis Ag | Metódos de administração de compostos agonistas da trombopoietina |
WO2011098095A1 (en) | 2010-02-09 | 2011-08-18 | Aplagen Gmbh | Peptides binding the tpo receptor |
WO2012102937A2 (en) | 2011-01-25 | 2012-08-02 | Irm Llc | Compounds that expand hematopoietic stem cells |
WO2013086436A1 (en) | 2011-12-08 | 2013-06-13 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
SG11201404241SA (en) | 2012-01-27 | 2014-08-28 | Univ Montreal | Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells |
US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
WO2015161373A1 (en) | 2014-04-22 | 2015-10-29 | Université de Montréal | Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells |
WO2016068270A1 (ja) | 2014-10-31 | 2016-05-06 | 日産化学工業株式会社 | リガンド結合繊維及び当該繊維を用いた細胞培養基材 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2950273A (en) * | 1956-11-20 | 1960-08-23 | Agfa Ag | Process for the production of symmetrical and unsymmetrical azo compounds |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
2000
- 2000-09-22 US US10/110,287 patent/US6552008B1/en not_active Expired - Fee Related
- 2000-09-22 EP EP00965329A patent/EP1223944B1/de not_active Expired - Lifetime
- 2000-09-22 WO PCT/US2000/026059 patent/WO2001021180A1/en active IP Right Grant
- 2000-09-22 ES ES00965329T patent/ES2279769T3/es not_active Expired - Lifetime
- 2000-09-22 DE DE60032783T patent/DE60032783T2/de not_active Expired - Fee Related
- 2000-09-22 JP JP2001524606A patent/JP2003509462A/ja active Pending
- 2000-09-22 AU AU76064/00A patent/AU771460B2/en not_active Ceased
- 2000-09-22 AT AT00965329T patent/ATE350044T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2001021180A1 (en) | 2001-03-29 |
AU7606400A (en) | 2001-04-24 |
DE60032783D1 (en) | 2007-02-15 |
DE60032783T2 (de) | 2007-12-06 |
EP1223944B1 (de) | 2007-01-03 |
JP2003509462A (ja) | 2003-03-11 |
US6552008B1 (en) | 2003-04-22 |
EP1223944A1 (de) | 2002-07-24 |
EP1223944A4 (de) | 2002-10-30 |
AU771460B2 (en) | 2004-03-25 |
ES2279769T3 (es) | 2007-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE350044T1 (de) | Thrombopoietinmimetika | |
DE60025632D1 (de) | Thrombopoietin-mimetika | |
DE60031714D1 (de) | Thrombopoietin-mimetika | |
MY136707A (en) | Thrombopoietin mimetics | |
WO2002049413A3 (en) | Thrombopoietin mimetics | |
WO2004054515A3 (en) | Thrombopoietin mimetics | |
EP1133291A4 (de) | Verfahren zur behandlung der thrombozytopenie | |
CY1108221T1 (el) | Μεθοδος για την αναπαραγωγη πλευρομουτιλινων | |
DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
DE60101265D1 (de) | Behandlung von augenschmerzen | |
ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
DE60101559D1 (de) | Benutzung von comt-inhibitoren als analgetika | |
DK1305037T3 (da) | Smertestillende medikament | |
DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen | |
ATE302008T1 (de) | Behandlung von entzündlichen erkrankungen | |
CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
BR0010699A (pt) | Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários | |
EA200100785A1 (ru) | Шипучие слабительные средства | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
DE60125035D1 (de) | Behandlung von plasmid-haltigen lösungen | |
LU91009B1 (de) | Behandlung von Verbrennungen | |
ATE294590T1 (de) | Verwendung von interleukin-11 zur behandlung von hämoragischem schock | |
UA35854A (uk) | Спосіб лікування приховано протікаючого силікотуберкульозу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |